Cannabis and Hemp Industry Investment News

AAA operates an 8,800 square foot (sq ft) indoor growing facility in London, Ontario "With the positive developments being experienced in Delta, BC at our Propagation Services Canada facility, the AAA Heidelberg subsidiary was deemed to be non-core to the company," said the CEO AgraFlora Organics International Inc (CSE:AGRA) (FRA:PU31) (OTCPINK:AGF

Namaste Technologies (CVE: N- OTC: NXTTF) CEO Meni Morim joined Steve Darling from Proactive to bring news the company has released their 2020 financial numbers. Morim shared with Proactive the numbers from a very busy 2020 and he has talked about the future of Namaste and where he sees the biggest opportunities for growth. Add related topics to My

The company also ended fiscal 2020 with $16.5 million in working capital as of November 30 Namaste said sales through its CannMart’s distribution channels made an important contribution to its record results  () () (FRA:M5BQ) reported 4Q net revenue climbed 85% year-over-year to a record C$7.2 million, which the company attributed primarily to an i

The maker of hard pill cannabinoid formulations said it can now fulfill the purchase order received from Australian hemp and medical cannabis group Cann Global Limited The $406,200 Cann Global order includes six stock keeping units Canntab Therapeutics Limited () (OTCQB:CTABF) (FRA:TBF1) said it has been granted an export license by Health Canada. 

In connection with the change, the company is implementing a share consolidation on a 25:1 basis In February, the company appointed Mervyn Pinto as CEO, CFO, and as a director of the company Mojave Jane Brands Inc (CSE:JANE) (OTCMKTS:HHPHF) (FRA:0HCN) has successfully rebranded as Mojave Brands Inc and its ticker symbol will change to ‘MOJO’ on the

Heritage Cannabis (CSE: CANN- OTCQX: HERTF) CEO Clint Sharples joined Steve Darling from Proactive to share details the company has announced the company will be launching several new medical products formulated with the patented VESIsorb delivery system technology in the U.S. Sharples telling Proactive the first product, through their subsidiary O

The company said the products have been formulated with VESIsorb for “optimized absorption, bioavailability, and rapid onset of action” Heritage subsidiary Opticann’s CBD/CBDA sublingual filmstrip will also be launched through its all-out e-commerce effort later this year Heritage Cannabis Holdings Corp (CSE:CANN) (OTCQX:HERTF) (FRA:2UE) revealed o

Lexaria Bioscience (CSE: LXX- Nasdaq: LEXXW) CEO Chris Bunka joined Steve Darling from Proactive to share news the company has released positive results from its extended stability testing for bottled CBD-containing beverages prepared using its technology. Bunka telling Proactive Lexaria’s DehydraTECH CBD nanoemulsification formulation and processi

GT is an award-winning, Nevada-based cannabis company with a strong brand portfolio of high-end dried flower and luxury derivative products Australis will pay the holders of the GT membership interests between C$8 million and C$10 million for 100% of the outstanding membership interests of both GT and the subsidiary Australis Capital Inc

The company reported that by using its DehydraTECH technology CBD beverages demonstrated 93.4% potency one year after production Lexaria's first patent was awarded in 2016 for CBD-infused beverages and consumable liquids Lexaria Bioscience Corp (NASDAQ:LEXX) () shared Wednesday positive results from its extended stability testing, which showed unpa

Umar Syed, president of Heritage’s medical and international business, said that "obtaining the distribution rights for VESIsorb products in Canada adds to our fast-growing suite of retail and medical product offerings” Heritage Cannabis said the agreement includes “strategic channels” in the Canadian marketplace Heritage Cannabis Holdings Corp (CS

FSD Pharma Inc (NASDAQ:HUGE) (CSE:HUGE) (FRA:0K9A) CEO Raza Bokhari talks to Proactive about the group's upcoming shareholder meeting on May 14, intended to address shareholder concerns. What's more, Bokhari says the company has formed a license agreement with Innovet Italia SRL to develop FDA-approved veterinary drugs for the treatment of gastroin